Stay updated with breaking news from Microba Life Sciences Ltd. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Microba Life Sciences Ltd (ASX:MAP) CEO Dr Luke Reid speaks to Proactive's Thomas Warner about the company's work in developing gut microbiome testing...
Microba Life Sciences Limited lists on the ASX today under code MAP after raising $30 million. The market capitalisation is ~$123 million (on an undiluted basis) at the Offer price of $0.45 per share.Microba is a commercial-stage company delivering gut microbiome testing services globally and driving the discovery o...